FIELD: medicine.
SUBSTANCE: invention is related to cholesterol-6-O-acyl-β-D-galactopyranoside intended for inducing in a host mammal of immune reaction on B.burgdorferi, where (i) residual acyl represents a group recovered from organic fatty acids containing 1-25 carbon atoms; (ii) galactopyranoside ring structure optionally contains acyl group recovered from fatty acid in any position of the ring. The invention also covers mixed 3-O-(6-O-palmitoyl-(β-D-galactopyranosyl)-cholesterol and 3-O-(6-O-oleoyl-β-D-galactopyranosyl)cholesterol intended for inducing in a host mammal of immune reaction on B.Burgdorferi.
EFFECT: compounds are especially effective for prevention or treatment of Lim's disease.
7 cl, 4 tbl, 15 dwg, 15 ex
Title | Year | Author | Number |
---|---|---|---|
SURFACE GLYCANS OF CLOSTRIDIUM PERFRINGENS AND THEIR USE | 2018 |
|
RU2798419C2 |
SPHINGOID POLYALKYLAMINE CONJUGATES FOR BACTERINATION | 2004 |
|
RU2361577C2 |
NUCLEIC ACID DELIVERY SYSTEM | 2002 |
|
RU2294192C2 |
OSPA CHIMERIC GENES, PROTEINS AND METHODS FOR USE THEREOF | 2011 |
|
RU2583289C2 |
APPLICATION OF NKG2D INHIBITORS FOR TREATING CARDIOVASCULAR AND METABOLIC DISEASES SUCH AS TYPE 2 DIABETES | 2010 |
|
RU2566264C2 |
MEDICINAL ANTIGEN CARRIER ENABLING TRANSMUCOSAL AND TRANSDERMAL ADMINISTRATION, METHOD OF MUCOSAL IMMUNITY INDUCTION, MUCOSAL VACCINE AND RELATED DRUG DELIVERY SYSTEM | 2005 |
|
RU2396090C2 |
DERIVATIVES OF PIPERIDINE, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2279425C2 |
CHIMERIC OSPA GENES, PROTEINS AND THEIR APPLICATION METHODS | 2011 |
|
RU2773402C2 |
IMMUNOMODULATING AGENT | 1989 |
|
RU2120302C1 |
SULFONYL UREA AND RELATED COMPOUNDS AND USE THEREOF | 2016 |
|
RU2739356C2 |
Authors
Dates
2010-03-27—Published
2004-04-02—Filed